Yi-Fan Tsai (left) hosted 17th Golden Torch Awards with James Ou (right), Chairman and CEO of Sage Pharmaceuticals.
Sage Pharmaceuticals: Game-Changer in Biotech, Wins Top 10 Outstanding Enterprises and Managers Award
The "Golden Torch Award" is a government-sponsored enterprise selection activity aimed at discovering and enhancing innovation and entrepreneurship in the country, promoting international competitiveness, commending outstanding domestic enterprises and enterprise managers, and enhancing corporate culture and image. In recent years, the global industry has slowed down due to the COVID-19 epidemic and the Ukrainian-Russian War, posing a challenge for leaders to find new paths, enhance competitiveness, and lead enterprises to higher levels. Despite this difficult environment, the Golden Torch Award continues to attract many domestic listed companies and well-known outstanding companies and leaders to sign up. Nearly 500 companies successfully entered the re-evaluation after the first round of preliminary evaluation, and after rigorous review by 28 domestic experts and scholars, the top ten outstanding enterprises and top ten outstanding managers in various fields were selected.
Sage Pharmaceuticals, Inc. is the biggest winner of this year's contest, winning two awards: "Top Ten Outstanding Enterprises" and "Top Ten Outstanding Managers". James Ou, the chairman and general manager of Sage Pharmaceuticals, Inc., won unanimous favor from the review committee for his corporate innovation and excellent business performance, becoming a big dark horse in the biotechnology industry.
Sage Pharmaceuticals has continuously innovated and made breakthroughs in the field of biotechnology, obtaining multinational invention patents. Its persistence and dedication to quality has won the International Quality Special Gold Award for four consecutive years. Despite the challenges posed by the epidemic, supply chain instability caused by geopolitics, and inflation, the company has maintained a stable growth rate in a difficult environment thanks to the continuous efforts of its team members. James Ou stated that receiving these two honors is an important affirmation of the team's past efforts.
Under the leadership of James Ou, Sage Pharmaceuticals adheres to a sustainable innovation business model, including product innovation and business model innovation. The company maintains technological leadership through continuous breakthroughs in product innovation. It also adopts a flexible marketing strategy to meet the various needs and consumption habits of customers in response to changes in the general environment. During the epidemic period, the company completed its digital transformation in response to the new form of consumption, "stay-at-home economy," leading to a nearly 70% increase in performance. It also expanded operations and established a demonstration brand company, IDAQS Biotech, Inc., and an international brand, UNID. In recent years, the company has also gradually improved its low-carbon footprint to pursue the goal of sustainable development.